The University Hospital Bonn plans to have a stronger focus on pharmacogenetics – thus emphasising the influence of genetic characteristics on the effect of medications. This idea embodies the approach for personalised medicine. To integrate extensive pharmacogenetic analysis into the clinical workflow, the Institute of Human Genetics at the University Hospital Bonn and HMG Systems Engineering GmbH (HMG) are establishing a partnership. The intended purpose is to provide the treating physician with clinically relevant information regarding pharmacologic and genetic interaction risks. That way, physicians are empowered to optimize the individual drug therapy for each patient.
Each human metabolises medication differently. Similar to the diverse factors forming diseases, the influences on the effect and tolerance of the prescribed medicine tend to be multifaceted. In addition to the age, weight, lifestyle and nutrition habits, and the intake of further medicines, patients’ genetic characteristics also impact the desired therapeutic effect.
In consideration of selected characteristics in the genome, pharmacogenetics enables an individual optimisation of the medication. Thus, patient-related risks and side effects can be reduced.
"The development of personalised therapies is making great progress."
"The pharmacogenetic profile of a patient can be critical in determining an optimal medication. Especially when several drugs are prescribed and interactions between them are to be expected," says Prof. Dr. Markus Nöthen, director of the Institute for Human Genetics at the University Hospital Bonn.
With its scientific working groups, it contributes to the research of the genetic causes of diseases and to the development of effective, individually tailored drug therapies and preventive measures.
“The partnership will enable us to use the innovative software and database developed by HMG and to introduce high-level pharmacogenetic diagnostics. In addition, a pilot project for patients at the University Hospital Bonn will be developed in the coming months. It is our vision that patients at our clinic benefit from the latest scientific knowledge in genetic medicine," says Prof. Nöthen.
“The future of medical technology is personalised medicine”
HMG has developed an IT platform, which interprets clinically relevant genetic information of the patient and its influences on individual drug metabolism. The software consists of own pharmacogenetic database. Considering 173 genetic variations, it constitutes the current state of research and is based upon up-to-date findings of science.
The database is complemented by a drug interactions check, evaluating the interactions of 40,000 drugs and 60 food and beverages. This enables physicians to optimise the patient’s medication in an even more precise, safe and efficient way.
“We are convinced that this medical technology will prospectively provide the appropriate drug with the right dose at the right time for each patient. We are delighted to partner with the renowned Institute of Human Genetics at the University Hospital Bonn and Prof. Markus Nöthen. Together we are taking a major step to translate pharmacogenetics basic research to clinical routine and medical prescription,” says Herna Muñoz-Galeano, founder and managing director of HMG Systems Engineering GmbH.
For more information about the Institute of Human Genetics at the University Hospital Bonn:
For more information about HMG Systems Engineering GmbH:
Prof. Dr. Markus Nöthen
Director of the Institute of Human Genetics
University Hospital Bonn
Telefon: 0228/ 287-51100
Managing director HMG Systems Engineering GmbH
Marketing & Communikations
HMG Systems Engineering GmbH
Telefon: 0911/ 97 91 08 57
Johannes Seiler | idw - Informationsdienst Wissenschaft
Study points to new drug target in fight against cancer
19.09.2019 | Rice University
Researchers develop tumour growth roadmap
19.09.2019 | Universität Leipzig
How long the battery of your phone or computer lasts depends on how many lithium ions can be stored in the battery's negative electrode material. If the battery runs out of these ions, it can't generate an electrical current to run a device and ultimately fails.
Materials with a higher lithium ion storage capacity are either too heavy or the wrong shape to replace graphite, the electrode material currently used in...
To process information, photons must interact. However, these tiny packets of light want nothing to do with each other, each passing by without altering the...
Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Hamburg and the European Molecular Biology Laboratory (EMBL) outstation in the city have developed a new method to watch biomolecules at work. This method dramatically simplifies starting enzymatic reactions by mixing a cocktail of small amounts of liquids with protein crystals. Determination of the protein structures at different times after mixing can be assembled into a time-lapse sequence that shows the molecular foundations of biology.
The functions of biomolecules are determined by their motions and structural changes. Yet it is a formidable challenge to understand these dynamic motions.
At the International Symposium on Automotive Lighting 2019 (ISAL) in Darmstadt from September 23 to 25, 2019, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, a provider of research and development services in the field of organic electronics, will present OLED light strips of any length with additional functionalities for the first time at booth no. 37.
Almost everyone is familiar with light strips for interior design. LED strips are available by the metre in DIY stores around the corner and are just as often...
Later during this century, around 2060, a paradigm shift in global energy consumption is expected: we will spend more energy for cooling than for heating....
19.09.2019 | Event News
10.09.2019 | Event News
04.09.2019 | Event News
20.09.2019 | Life Sciences
20.09.2019 | Life Sciences
20.09.2019 | Life Sciences